The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States.
The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.
STATEMENT BY MARGARET A. HAMBURG, COMMISSIONER OF FOOD AND DRUGS, ON THE REOPENING OF SOME LOUISIANA STATE WATERS TO COMMERCIAL FISHING (HR)
Qualcomm Announces Collaboration with Global Holding Corporation and Tulip Telecom in New India LTE VentureJuly 29, 2010 10:47 pm | by Qualcomm | News | Comments
Qualcomm Announces Collaboration with Global Holding Corporation and Tulip Telecom in New India LTE VentureMUMBAI, INDIA – July 29, 2010 – Qualcomm Incorporated (NASDAQ: QCOM), the winner of B
The U.S. Food and Drug Administration is warning that inadvertent exposure to Evamist through skin contact with patients using this product has the potential for adverse effects in children and pets.
More than 100 food safety reports were submitted by industry to the U.S. Food and Drug Administration’s new electronic portal in its first months of operation, the agency said today.
The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.
Discovery Communications Launches Dedicated Mobile Channel on FLO TV, Bringing the World’s Wonders to Viewers on the GoJuly 28, 2010 5:48 am | by Qualcomm | News | Comments
Discovery Communications Launches Dedicated Mobile Channel on FLO TV, Bringing the World’s Wonders to Viewers on the GoSAN DIEGO and SILVER SPRING, MD – July 28, 2010 – FLO TV Incorporated, a wh
Qualcomm Announces Project to Enable 3G Health Care Access For Rural Japanese CommunitiesTOKYO and SAN DIEGO – July 21, 2010 – Qualcomm Incorporated (NASDAQ: QCOM) and Medical Platform Asia (Me
Owners agree to keep illegal drug residues out of animals sold for human consumption A Pennsylvania dairy farm has agreed to abide by federal regulations that protect meat from illegal drug residues caused by the unapproved medication of cattle before slaughter, as part of a consent...
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a potentially deadly blood clotting condition.
At the request of the U.S. Food and Drug Administration, U.S. Marshals today seized $346,954.43 worth of FastSize Extender devices and FastSize EQM Erectile Quality Monitor devices, as well as component parts used in the manufacture of the FastSize Extender. The FastSize Extender and the...
Heart device maker Thoratec Corp. said Tuesday it agreed to cancel the $110 million sale of its diagnostic test business to Danaher Corp.
Over 70,000 children and teens go to the ER each year for injuries and complications from medical devices, the first detailed national estimate suggests.
Becton, Dickinson and Co., a global medical device maker, plans to expand in North Carolina, building a new East Coast distribution center that will employ nearly 190 by 2015.
Medical equipment maker says government's new rules on 'meaningful use' of computerized health records will make compliance 'a more realistic prospect.'
J&J said Monday it will pay $480 million for medical device maker Micrus Endovascular, adding a range of treatments for stroke and brain aneurysms.
Ethicon Endo-Surgery, a unit of Johnson & Johnson, said Monday it completed the sale of its breast cancer business to Devicor Medical Products.
Medical device maker Biomet Inc. planning a $26 million expansion of its northern Indiana facilities that could add about 280 jobs.
Drug and medical device maker Covidien said Monday it completed a tender offer for ev3 Inc. and moved closer to closing its $2.6 billion buyout of the company.
Toronto-based medical imaging technology company is being taken over by SonoSite in a $71-million deal that includes assumption of $8 million of VisualSonics debt.
Cochlear Americas has agreed to pay $880,000 to the U.S. government to resolve allegations that it paid kickbacks to doctors.
A 2.3 percent excise tax will cost medical device manufacturers an estimated $20 billion in new taxes over the next decade, which could force them to lay off workers.
Health care products maker plans to launch 80 new products through 2012 and expand in markets including biosurgicals and electrophysiology.